KR100553154B1 - Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 - Google Patents
Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100553154B1 KR100553154B1 KR1020020064380A KR20020064380A KR100553154B1 KR 100553154 B1 KR100553154 B1 KR 100553154B1 KR 1020020064380 A KR1020020064380 A KR 1020020064380A KR 20020064380 A KR20020064380 A KR 20020064380A KR 100553154 B1 KR100553154 B1 KR 100553154B1
- Authority
- KR
- South Korea
- Prior art keywords
- vector
- protein
- expression
- pcmv
- cells
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
- HIV NC(nucleocapsid) 유전자의 상부에 SV40 19s mRNA 인트론 서열 또는 변형된 SV40 16s mRNA 인트론 서열을 연결시키는 단계를 포함하는 HIV NC 단백질의 동물세포 발현용 벡터의 제조방법.
- 제1항에 있어서, 상기 동물세포는 COS-7 세포 또는 293T 세포인 것을 특징으로 하는 제조방법.
- 제1항 또는 제2항에 있어서, 상기 벡터는 상기 NC 유전자의 상부에 FLAG 유전자가 추가로 연결된 것을 특징으로 하는 제조방법.
- 프로모터, SV40 19s mRNA 인트론 서열 또는 변형된 SV40 16s mRNA 인트론 서열, FLAG 유전자 및 HIV NC 유전자를 순차적으로 포함하고, 도 5에 도시된 개열지도를 갖는 것을 특징으로 하는 HIV NC 단백질의 동물세포 발현용 벡터.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020064380A KR100553154B1 (ko) | 2002-10-21 | 2002-10-21 | Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020064380A KR100553154B1 (ko) | 2002-10-21 | 2002-10-21 | Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040034278A KR20040034278A (ko) | 2004-04-28 |
KR100553154B1 true KR100553154B1 (ko) | 2006-02-22 |
Family
ID=37333627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020064380A KR100553154B1 (ko) | 2002-10-21 | 2002-10-21 | Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100553154B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100987004B1 (ko) | 2007-02-27 | 2010-10-11 | (주) 에빅스젠 | Aids 예방 및 치료 물질 스크리닝용 재조합 포유동물세포 및 이를 이용한 스크리닝 방법 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101158755B1 (ko) * | 2006-12-20 | 2012-06-22 | (주) 에빅스젠 | Hiv nc 단백질 발현용 벡터 및 이를 이용한 nc단백질의 생산방법 |
WO2008075911A1 (en) * | 2006-12-20 | 2008-06-26 | Avixgen Inc. | Vector for expressing nc protein of hiv and method for producing nc protein using the same |
KR101138930B1 (ko) * | 2007-02-16 | 2012-04-25 | (주) 에빅스젠 | Hⅰv nc 단백질을 포함하는 aⅰds 예방 및 치료용조성물 |
WO2008105604A1 (en) * | 2007-02-27 | 2008-09-04 | Avixgen Inc. | Recombinant mammalian cell for screening a substance preventing and treating aids and screening method using the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010090959A (ko) * | 2000-04-08 | 2001-10-22 | 유지창 | 사람의 면역결핍바이러스 억제제의 탐색을 위한 형질전환체 |
US6365150B1 (en) * | 1998-05-13 | 2002-04-02 | Genetix Pharmaceuticals, Inc. | Lentiviral packaging cells |
-
2002
- 2002-10-21 KR KR1020020064380A patent/KR100553154B1/ko not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365150B1 (en) * | 1998-05-13 | 2002-04-02 | Genetix Pharmaceuticals, Inc. | Lentiviral packaging cells |
KR20010090959A (ko) * | 2000-04-08 | 2001-10-22 | 유지창 | 사람의 면역결핍바이러스 억제제의 탐색을 위한 형질전환체 |
Non-Patent Citations (3)
Title |
---|
J Biol Chem. 1993 Aug 5;268(22):16519-27 * |
J Virol. 1999 Oct;73(10):8527-40 * |
Protein Expr Purif. 1998 Oct;14(1):54-64 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100987004B1 (ko) | 2007-02-27 | 2010-10-11 | (주) 에빅스젠 | Aids 예방 및 치료 물질 스크리닝용 재조합 포유동물세포 및 이를 이용한 스크리닝 방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20040034278A (ko) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113631708B (zh) | 编辑rna的方法和组合物 | |
Tsai et al. | Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. | |
Ogawa et al. | PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. | |
DK2951309T3 (en) | INCREASED TRANSGEN EXPRESSION AND PROCESSING | |
EP1002091B1 (en) | Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue | |
Duprex et al. | Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame | |
CA2346155A1 (en) | Enzymatic synthesis of ssdna | |
CN109295053B (zh) | 通过诱导剪接位点碱基突变或多聚嘧啶区碱基置换调控rna剪接的方法 | |
Wu et al. | Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells | |
CN111979198A (zh) | 使用zscan4复壮人细胞的方法 | |
IL301621A (en) | Transposition of nucleic acid constructs into eukaryotic genomes with amylase transposases | |
WO2019041344A1 (en) | METHODS AND COMPOSITIONS FOR THE TRANSFECTION OF SINGLE STRANDED DNA | |
US7037648B1 (en) | Somatic transfer of modified genes to predict drug effects | |
CN116113697A (zh) | 用于治疗癫痫的方法和组合物 | |
KR100553154B1 (ko) | Hiv 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 | |
US6692910B2 (en) | Inhibition of a target messenger RNA with a modified U1 small nuclear RNA | |
Freyaldenhoven et al. | Aberrant cell growth induced by avian winged helix proteins | |
KR20220045013A (ko) | Lama1 유전자를 표적으로 하는 근이영양증의 치료 방법 | |
Goraya et al. | Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin-converting enzyme gene | |
Lee et al. | Importance of basic residues in binding of Rous sarcoma virus nucleocapsid to the RNA packaging signal | |
Camerini et al. | A dormant internal ribosome entry site controls translation of feline immunodeficiency virus | |
JP5676140B2 (ja) | ヒト癌化細胞の作製方法 | |
US20150197803A1 (en) | Method for Detecting or Measuring the Impact of a Viral Vector Composition on Eukaryotic Cells and Biomarkers Used Thereof | |
Ou et al. | Role of a conserved amino-terminal sequence in the ecotropic MLV receptor mCAT1 | |
WO2024041653A1 (zh) | 一种CRISPR-Cas13系统及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120209 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee | ||
FPAY | Annual fee payment |
Payment date: 20141023 Year of fee payment: 9 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20150810 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160105 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170206 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180208 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190131 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20200210 Year of fee payment: 15 |